ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

The University of Manchester at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

The University of Manchester takes part in 10 sessions at ESMO 2026 in Madrid. Its research spans pancreatic and liver cancer patterns, tumor genetics and treatment. It examines how age, sex, ethnicity and metabolic conditions relate to cancer trends, and how tumor mutations may relate to treatment outcomes.

OrganizationESMO 2026 Attendance
The University of Manchester
Manchester, United Kingdom
University & institute
Research university with a medical school and cancer research in Manchester, United Kingdom.
Poster
Fri Oct 23
13:00–15:00
KRASG13D mutant lung adenocarcinoma: Clinicogenomic features and therapeutic vulnerabilities
ePoster session 13
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Alectinib as a tumour-agnostic intervention for ALK fusion-positive cancers: The DETERMINE trial
Friday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancers
Poster
Sat Oct 24
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Talk
Mon Oct 26
08:45–09:00
Presentation by Expert 2: Cracking the code - Multi-omics for advanced melanoma
Too big to scale? NGS in the setting of melanoma
Melanoma & skin cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The University of Manchester

Tell us what you sell and we’ll find the people at The University of Manchester most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction